Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
NCT05557604
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
146
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Decapeptyl
Sponsor
Regina Elena Cancer Institute